Neoadjuvant target therapy of differentiated thyroid cancer (clinical observation)
In the article a case of non-resectable differentiated thyroid cancer (DTC) is described. A recurrent thyroid tumor deforms the oropharyngeal lumen and laryngeal vestibule and bears down on the left esophageal wall and trachea. The authors present literature data on Nexavar target therapy and focus...
Main Authors: | P. A. Isaev, S. V. Vasilkov, I. S. Pimonova, F. E. Sevrukov, V. V. Polkin, D. Yu. Syomin, A. A. Ilyin, V. S. Medvedev, N. K. Silantyeva, T. A. Agababyan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2017-04-01
|
Series: | Опухоли головы и шеи |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/242 |
Similar Items
-
TARGET THERAPY OF HIGH DIFFERENTIATED CARCINOMA RESISTANT TO RADIOIOD THERAPY (REVIEW OF LITERATURE)
by: S. V. Vasilkov, et al.
Published: (2017-11-01) -
Efficacy of external beam radiotherapy and targeted therapy with vandenanib in patients with inoperable and progressive medullary thyroid cancer
by: A. D. Kaprin, et al.
Published: (2018-11-01) -
Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
by: E. V. Borodavina, et al.
Published: (2022-02-01) -
Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
by: E. V. Borodavina, et al.
Published: (2020-04-01) -
Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
by: А. М. Mudunov, et al.
Published: (2019-10-01)